rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2010-5-24
|
pubmed:databankReference |
|
pubmed:abstractText |
Depression is common in patients with Parkinson's disease, but evidence on the efficacy of antidepressants in this population is lacking. Because depression in patients with Parkinson's disease might be related to dopaminergic dysfunction, we aimed to assess the efficacy of the dopamine agonist pramipexole for treatment of depressive symptoms in patients with Parkinson's disease.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1474-4465
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2010 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
573-80
|
pubmed:dateRevised |
2011-5-16
|
pubmed:meshHeading |
pubmed-meshheading:20452823-Aged,
pubmed-meshheading:20452823-Antidepressive Agents,
pubmed-meshheading:20452823-Antiparkinson Agents,
pubmed-meshheading:20452823-Benzothiazoles,
pubmed-meshheading:20452823-Depressive Disorder,
pubmed-meshheading:20452823-Dopamine Agonists,
pubmed-meshheading:20452823-Double-Blind Method,
pubmed-meshheading:20452823-Dyskinesias,
pubmed-meshheading:20452823-Europe,
pubmed-meshheading:20452823-Female,
pubmed-meshheading:20452823-Humans,
pubmed-meshheading:20452823-Male,
pubmed-meshheading:20452823-Parkinson Disease,
pubmed-meshheading:20452823-Psychiatric Status Rating Scales,
pubmed-meshheading:20452823-Severity of Illness Index,
pubmed-meshheading:20452823-South Africa,
pubmed-meshheading:20452823-Time Factors,
pubmed-meshheading:20452823-Treatment Outcome
|
pubmed:year |
2010
|
pubmed:articleTitle |
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
|
pubmed:affiliation |
Department of Neurological Sciences, University of Naples Federico II and IDC Hermitage Capodimonte, Naples, Italy. barone@unina.it
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|